Article
Development and Validation of the Chemotherapy-induced Peripheral Neuropathy Integrated Assessment – Oxaliplatin Subscale: A Prospective Cohort Study
2023-08-10
Abstract excerpt
<h4>Background: </h4> Current assessment tools for chemotherapy-induced peripheral neuropathy (CIPN) have rarely provided substantive guidance for interventions in clinical applications. The aim of this study was to develop an assessment tool specifically for oxaliplatin-induced peripheral neuropathy (OIPN), and to improve the accuracy, sensitivity and practicability of clinical assessment. Methods This study scr...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- b41dd3c2-1b56-58ee-8281-416c0bfaef37
- DOI
- 10.21203/rs.3.rs-3128915/v1
